Affiliation:
1. Department of Forensic Sciences University of New Haven West Haven Connecticut USA
Abstract
AbstractUnintended compounds produced by inexperienced clandestine chemists may present a challenge in laboratories tasked with their identification. In March 2020, an anonymously submitted tablet purchased as a generic form of Xanax was analyzed by Erowid's DrugsData.org. The gas chromatography–mass spectrometry (GC–MS) results publicly released online indicated several unidentified compounds due to a lack of database references at that time. Elucidation by our group indicated the presence of several structurally related compounds that were linked to a failed synthesis of alprazolam. For this case study, a published procedure for the synthesis of alprazolam starting with the chloroacetylation of 2‐amino‐5‐chlorobenzophenone was identified as a potential source of this failure. The procedure was reproduced to identify pitfalls of the methodology and examine its possible link to the illicit tablet. Reaction outcomes were analyzed via GC–MS and compared to the tablet submission data. The major compound in this submission, N‐(2‐benzoyl‐4‐chlorophenyl)‐2‐chloroacetamide, along with several related byproducts were successfully reproduced indicating that the tablet contents potentially stem from a failure to synthesize alprazolam.
Subject
Genetics,Pathology and Forensic Medicine
Reference25 articles.
1. GABAA receptor: Positive and negative allosteric modulators
2. Benzodiazepines: Their Use either as Essential Medicines or as Toxics Substances
3. Balancing the Risks and Benefits of Benzodiazepines
4. U.S. Food and Drug Administration.FDA Drug Safety Communication: FDA requiring boxed warning updated to improve safe use of benzodiazepine drug class. 09‐23‐2020. [cited 2023 May 23]. Available from:https://www.fda.gov/drugs/drug‐safety‐and‐availability/fda‐requiring‐boxed‐warning‐updated‐improve‐safe‐use‐benzodiazepine‐drug‐class